You are here
Non-topical non-inhaled corticosteroids
Gastric ulcer and duodenal ulcer - Non-topical non-inhaled corticosteroids Factor
Last reviewed for CCPS 24 May 2007.
Investigative Documents
Medical Report - Non-topical, Non-inhaled Corticosteroids - Gastric Ulcer and Duodenal Ulcer [MR9373] Preliminary questions [37637]
37642 the veteran was treated with non-topical non-inhaled corticosteroids, at a dose equivalent to at least 10 milligrams per day of prednisolone, for a continuous period of at least two weeks at some time. the veteran was treated with non-topical non-inhaled corticosteroids, at a dose equivalent to at least 10 milligrams per day of prednisolone, for a continuous period of at least two weeks for an illness or injury which is identifiable. 37639 — the veteran has established the causal connection between treatment with non-topical non-inhaled corticosteroids and operational service for gastric ulcer or duodenal ulcer. 37640 — the veteran has established the causal connection between treatment with non-topical non-inhaled corticosteroids and operational service for the clinical onset of gastric ulcer or duodenal ulcer. or 37641 — the veteran has established the causal connection between treatment with non-topical non-inhaled corticosteroids and operational service for the clinical worsening of gastric ulcer or duodenal ulcer. Clinical onset and operational service [37640] 37646 — the identified illness or injury, for which the veteran was treated with non-topical non-inhaled corticosteroids, at a dose equivalent to at least 10 milligrams per day of prednisolone, for a continuous period of at least two weeks, is causally related to operational service. Clinical worsening and operational service [37641] 37646 — the identified illness or injury, for which the veteran was treated with non-topical non-inhaled corticosteroids, at a dose equivalent to at least 10 milligrams per day of prednisolone, for a continuous period of at least two weeks, is causally related to operational service.